This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Healthy Volunteers
and you are
between 18 and 55
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The purpose of this study is to evaluate the oral bioavailability of two new tablet formulations of TAK-385 (T4 Formulation B and T4 Formulation C) under fasted and fed conditions, relative the T2 Formulation tablet; and to estimate the effect of food on the pharmacokinetics (PK) of a single oral dose of the T4 Formulation B tablet and the T4 Formulation C tablet.

Provided treatments

  • Drug: TAK-385 T2 Formulation
  • Drug: TAK-385 T4 Formulation B
  • Drug: TAK-385 T4 Formulation C
Tris trial is registered with FDA with number: NCT02396147. The sponsor of the trial is Takeda and it is looking for 54 volunteers for the current phase.
Official trial title:
A Phase 1, Open-Label, Randomized, Three-Way Crossover Study Evaluating the Relative Bioavailability and Effect of Food on TAK-385 Tablet Formulations in Healthy Subjects